PTK2 and neoplasm: In vivo studies on mice bearing ovarian tumors revealed that the reduction of ECM stiffness through gene silencing of FAK and the gene editing of PD‐L1, with the consequent suppression of the immune inhibition, effectively inhibited tumor growth and increased the infiltration of immune cells in the tumor tissue (Figure 8D,E).